As the BSMB found that the trial can continue without changes to the protocol it would imply that the 15 US Rett patients are also on 5mg.
It could be a toxicity concern, but it could also be that in Rett the patients need less A2-73 because their brains are not damaged from the years of lifestyle and age issues that contribute to developing AD.